Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Four Countries, Four Proteins, One Answer—γ-Secretase a Tetramer
11 October 2007. Researchers in the U.S., Japan, Belgium, and Germany have joined forces to find out how Pen-2, Aph-1, presenilin, and nicastrin do the same. The four proteins are well-known components of γ-secretase, the intramembrane protease that releases amyloid-β from its precursor. That much is clear. What is murkier is how many molecules of each protein go into the protease complex. The answer is one, according to Michael Wolfe, Brigham and Women’s Hospital, Boston, and collaborators in Yasuo Ihara’s lab, University of Tokyo; Bart De Strooper’s lab, KULeuven; and Christian Haass’ lab, Ludwig Maximilians University, Munich.

The one-for-all stoichiometry makes life somewhat simpler than the alternative proposition, which is that the complex contains a presenilin (PS) dimer at the core. Since there are two presenilins (and more than 100 different PS missense mutations identified) a dimer increases the number of different active sites that can be formed.

A definitive answer to this primer/dimer question has remained elusive. The closest researchers have gotten to a structural image of γ-secretase is a 3D electron micrograph, but that did not have sufficient resolution to determine if one or two PS proteins are present (see ARF related news story). Wolfe and colleagues used a biochemical approach. In the October 2 Journal of Biological Chemistry online, first author Toru Sato and colleagues show that immunoprecipitation of the complex always pulls down one presenilin, even if two are present in the cell. For example, when the researchers expressed both myc- and hemagglutinin-tagged PS in PS1/2 double knockout cells, anti-myc never pulled down HA-PS, and anti-HA never pulled down myc-PS. Both antibodies pulled down γ-secretase activity, however, suggesting that active protease can form with a single presenilin. Sato and colleagues obtained similar results when they carried out the experiments in the presence of γ-secretase substrates or inhibitors, just in case dimers may form under conditions that change PS conformation. The results suggest that does not happen, either.

Sato and colleagues then used the knowledge that there is only one PS per complex to quantify the amount of the three other components, arriving at the 1:1:1:1 stoichiometry. This predicts a molecular weight of around 220 kDa. However, native gel electrophoresis indicates the complex is around 300-800 kDa. The authors write that they cannot rule out the possibility that other proteins or substrates contribute to the size of the complex, but they also note that some electrophoretic methods can be “fraught with difficulties.” Another possibility these findings cannot rule out is that two or more γ-secretases form larger complexes in cells, albeit each γ-secretase with a single active PS. What the researchers do rule out is “the suggestion that one PS can affect another PS,” or that “one FAD mutant PS molecule can alter the site of proteolysis by wild-type PS.”—Tom Fagan.

Reference:
Sato T, Diehl TS, Narayanan S, Funamoto S, Ihara Y, De Strooper B, Steiner H, Haass C, Wolfe MS. Active gamma-secretase complexes contain only one of each component. J Biol Chem. 2007 Oct 2;56:1-13. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad